This prospective study was performed to observe effect of Tamsulosin on stone clearance after Extra-corporeal Shock Wave Lithotripsy (ESWL) 
Abstract
The removal and elimination of the calculi from the ureters depends not only on their size and shape but also on the intensity of the contractibility and irritation of the adrenoceptors present in the smooth mucles of the ureters and detrusor. In the transport of stones the greatest obstacle is usually formed by
Introduction
Urolithiasis is the third most common disease of the urinary tract, exceeded only by urinary tract infections and pathologic conditions of the prostate . 1 Urolithiasis affects 4% to 15% of the world population, and the incidence of this is increasing, especially in Europe. 2 Stone fragment expulsion after renal ESWL is probably not dissimilar to spontaneous discharge. Though there is no exact data about its prevalence in Bangladesh but the problem is quite common. Renal stone disease may be complicated by pyonephrosis, septicaemia, pyelonephritis, hydronephrosis, renal failure and even death. So, early and appropriate treatment is necessary to protect renal function and to avoid some grave complications. Management of urolithiasis ranges from conservative watchful waiting to traditional bleeding disorders, severe cardiopulmonary disorders, radioluscent stones, elevated serum creatinine (>2mg/dl), high grade hydronephrosis, diabetes mellitus, concomitant treatment with calcium antagonist or alpha receptor antagonist, congenital anomalies of urinary tract, previous urological surgery causing ureteric stricture, bladder outlet obstruction etc, neuropathic bladder, severe skeletal deformity, morbid obesity. Variables were stone size, location of stone, stone clearance, episodes of colic and other complications after ESWL. Detailed history was taken and clinical examination was done for each patient and recorded in predesigned data entry form. Before ESWL all patients were investigated with total blood count, serum creatinine, random blood sugar, coagulation profile, urine examination and Electrocardiography.
Ultrasonogram and intravenous urography were done in all patients to observe renal excretion and size, location of stone. Prophylactic antibiotic was given to all the patients 24 hours before the ESWL procedure. ESWL monotherapy with Siemens Lithostar plus (3'a generation) lithotriptor was used to fragment the renal stone. All the patients were given intravenous fluid and analgesic suppository prior to the procedure. In supine position on the ESWL table stone located by fluoroscopy and stones were fragmented. Amount of energy given in each patient was 4Kv to 5.5Kv with an average of 4.7Kv. The patients with successful fragmentation of stone were randomly divided equally into two groups. Patients of group I were allowed to take minimum 2.0 liter water daily and analgesics if required (75 mg diclofenac injection). Patients of group II were instructed to take additional oral Tamsulosin.0.4 mg daily for maximum three weeks. All patients of both groups were asked to compile a diary about postdischarge pain, stone expulsion, episodes of colic, analgesic use and side effects of drug. All patients were observed weekly for three weeks to see stone clearance. In each follow up, patients were evaluated with X-ray and urine examination was done and data were recorded in data sheet. During follow up period, the patients who developed complications e.g. pain, hematuria, lower urinary tract symptoms (LUTS), ureteral colic has been managed by additional therapies like antibiotics, analgesics, sedatives, etc. Those patients who were refractory to medical management have treated with interventional therapy. After collection of data, statistical analysis was done using computer SPSS 12.0 version and manual technology. Test of significance was done the terminal part of the ureters, mainly in its intramural "detrusor tunnel". Based on the molecular and pharmacological diversity of the effect of ?-1 blockers, subtype alpha IID, which has the most pronounced effect on the detrusor relaxation, and the spasm of the lower part of ureters and espacially on its intramural part. 5 Several studies have shown that the density of alpha IID-adrenergic receptors in the ureteral smooth muscle cells is greater than in other adrenergic receptors. In addition, the alpha adrenergic antagonists are able to inhibit basal tone and peristaltic frequency, dilating the ureteral lumen and facilitating stone passage. Some investigators have reported the effectiveness of pharmacologic therapies in increasing ureteral stone expulsion and reducing total analgesic use. 6 Tamsulosin, an alpha-1 receptor blocker usually used to relax prostatic smooth muscles owing to its inhibitory effect on alpha l-A receptors, but it also can affect on alpha 1-D receptors of ureteric smooth muscles facilitating passage of stone fragments after ESWL. To our knowledge, only a few studies however, has defined the contribution of Tamsulosin in the success of ESWL for renal stones. One such study was performed in our country regarding ureteric stone clearance though not after ESWL. For this reason, we planned to use Tamsulosin, as adjunctive therapy, to verify its role in renal stone fragment expulsion after a single ESWL treatment. Methodology This was a randomized controlled trial. This study was carried out in Department of urology, Bangabondhu Sheikh Mujib Medical University (BSMMU), Dhaka, during the period of July 2006 to May 2007. Patients with renal stone came in this hospital were selected according to the selection criteria and included in this study. After successful fragmentation of renal stone by ESWL, patients over 15 years of age were collected randomly for this study. The total number of study population was 80, who were equally divided in two groups. In group 1, as randomized controlled group all patients were given traditional hydrotherapy after ESWL. In group 2, as randomized trial group all patients were given additional Tamsulosin 0.4 mg daily orally with traditional therapy. The inclusion criterions were solitary radioopaque stone in upper or middle calyx or in renal pelvis, stone size-6-20mm, sterile urine, excreting kidneys etc. On the other hand exclusion criterions were age <15 years, any concomitant renal stone, stone size-<6mm,>20mm, lower calyceal stone, diseased opposite kidney, urinary tract infection, pregnancy, separate instructions were given to both groups of patients. Within next 3 weeks significant number of patients became stone free. There was significant difference in clearance of stone between the groups (Table I) . In this study, gradually increased number of patients became stone free in subsequent week following post ESWL additional Tamsulosin therapy (group II) but this type of increment was not observed in patients who followed post ESWL hydrotherapy alone.
After ESWL complications developed in some patients of both groups. Most of the patients were improved on the same day. Among total 35 patients who developed some sorts of complication after ESWL, 23 patients were from group I and 12 patients were from group 2 which was statistically significant. All patients of Group II had episodes of colic during follow up period but only a few patients of Group I. During the follow up period some patients of both groups needed additional treatment. Additional treatment required in group I and II was 57.50% and 47.5% respectively which is not significant statistically. In group I, 23 patients were subjected to take additional treatment of whom 12 patients were taken medical therapy and 11 patients were needed additional intervention which is not significant statistically. In group II, 19 patients were subjected to take additional treatment of which 16 patients taken medical therapy but only 3 patients needed additional intervention which is statistically significant.
had a favorable impact on the clearance of residual fragments after ESWL. In this study, stone clearance was 57.5% and 80% among group I (traditional hydrotherapy) and group II (additional Tamsulosin) respectively. Here statistical analysis shows significant difference of clearance (P<0.05) which is more or less similar to another study where post ESWL stone clearance rate after 3 months follow up with traditional hydrotherapy and analgesic and with additional Tamsulosin was 60% and 78.5% respectively. 6 In group I of this study, 35% patients were in stone size between 6-10 mm and 65% were in stone size between 11-20 mm and in group II, 45% had stone size between 6-10 mm and 55% had stone size between 11-20 mm. The above distribution correlates other study having stone size between 4-10 mm and 11-20 mm in each group but does not correlate with the another study having stone size of < 20 mm and 20 or > 20 mm in each group. 6, 11 In this study, stone clearance in group I was 100% and 34.6% for smaller (6 to 10 mm) and larger stones (11-20 mm) respectively and in group II, 77.8% and 81.8% for smaller and larger stones indicates lower clearance rate in larger stones in group I but higher clearance rate in larger stones in group II. This observation may be due to lower spontaneous expulsion rate of fragments of stone of large size and due to more facilitating effect of Tamsulosin in stone clearance preferably in larger size of stone. Again
Discussion
The present study has been designed to assess the effectiveness of Tamsulosin than traditional therapy (Hydrotherapy) after ESWL for renal stone of 6-20 mm size. Several variables play a fundamental role for the migration process of stone fragments: stone size, intrinsic areas of narrowing within the ureter, ureteral peristalsis and edema, infection, and spasm of the ureter at the site at which the stone is lodged. Edema, infection, spasm, and ureteral peristalsis could be modified by an appropriate medical therapy. Some investigators have reported the effectiveness of different pharmacologic therapies in increasing ureteral stone expulsion by acting primarily on spasm and ureteral peristalsis. In a study, association of nifedipine and steroids improved the rate of ureteral stone expulsion and reduced the time for stone passage. 7 Furthermore, alpha l-adrenergic antagonist can cause a decrease in ureteral peristaltic frequency, reducing ureteral spasm. These changes are accompanied by an increase in the rate of fluid transport.
8 In this regard, several studies have demonstrated that lower tract ureteral stones can be treated efficiently with different types of alpha lblockers with a low incidence of side effects. Of the available alpha l -blockers, Tamsulosin has been chosen because it is a combined alpha lA and alpha lD-selective adrenergic antagonist. In this study it was observed that 3 weeks of Tamsulosin therapy 
